Jul 2014, Tazobactam and Sulbactam were zero-defect approved by US FDA.
Apr 2013, documents of decalration to go public were accepted by China Securities Regulatory Commission
Aug 2012, the company was renamed “Jiangxi Fushine Pharmaceutical Co., Ltd”
May 2012, the APIs approved the new GMP certification
Sep 2011, Fushine was recognized as a High-tec enterprise.
Nov 2010, Fushine was recognized as “Jiangxi Provincial Enterprise Technology Center”
Oct 2010, the wholly-owned subsidiary Jiangxi Xiangtai Pharmaceutical Co., Ld was founded
May 2009, obtained Drug Manufacturing Certificate and became a real drug manufacturing enterprise
Feb 2009, the new pilot put into production.
Jun 2007, new cGMP stardand factory covering an area of 123 mu, invested 200 million RMB was launched.
Jul 2004, granted by ISO9001 Quality Management System Certification
Mar 2003, obtained the right to import and export independently.
Dec 2002, the company was renamed “Jingdezhen Fuxiang Pharmaceutical Co., Ltd”
Mar 2002, “Jingdezhen Fuxiang Pharmaceutical Chemical Co., Ltd” was founded.